39 research outputs found
Penetration of pefloxacin into bronchial secretions.
Twelve patients, intubated for acute exacerbation of chronic obstructive pulmonary disease, received six intravenous doses of 400 mg of pefloxacin at 12-h intervals. Samples of blood and bronchial secretions were taken simultaneously, before the injection and at 0.5, 3, 6, 9, and 12 h after the end of the sixth infusion. There was a large variation in pefloxacin levels in both serum and bronchial secretions. The mean concentrations of pefloxacin in bronchial secretions ranged from 6.51 to 11.1 micrograms/ml and were higher than the corresponding concentrations in serum at all times. Of 61 bronchial specimens, 48 (79%) contained more than 8 micrograms of the antibiotic per ml
Long-term evaluation of safety and efficacy of pitolisant in narcolepsy: harmony 3 study
Identification of a novel role for autotaxin in microglial cells submitted to oxidative stress
International audienc
Long-term evaluation of safety and efficacy of pitolisant (wakix®), an histamine H3R antagonist, in narcolepsy
Cefepime versus ceftazidime in the treatment of pyelonephritis - a European study of 300 pediatric cases.
Identification of a novel role for autotaxin in microglial cells submitted to oxidative stress
International audienc
Identification of a novel role for autotaxin in microglial cells submitted to oxidative stress
International audienc
